All About Multiple Sclerosis

More MS news articles for April 2004

Serono study says Rebif drug can reduce brain lesions

April 28, 2004
Steve Goldstein
CBS MarketWatch

Swiss biotech Serono (SRA) on Wednesday said a study said its Rebif drug can reduce the long-term accumulation of brain lesion volume in remitting multiple sclerosis drug. The study was presented at the annual American Academy of Neurology meeting.

Copyright © 2004, MarketWatch